Transforming the Core of a Pharma R&D

Challenges and tasks

A global leading pharma company dedicated to the research, development and distribution of innovative prescription therapeutic products needed to:

  • Create a new CMC (Chemistry Manufacturing and Controls – the ‘core’ of a Pharma R&D department) unit out of three existing departments;
  • Build an organization structure and capabilities to be able to work with a larger portfolio of earlier-phase developments; and
  • Improve skills for partnering with 3rd party R&D providers (CROs, CMOs).

OXYGY's Approaches

  • Mapping & documenting of the development process
  • Co-designing a new organization set up for the CMC
  • Supporting targeted development interventions for both Leadership and functional teams
  • Supporting clarification of the critical performance indicators for the CMC and defining simple set of KPIs for process steps

Outcomes and value created

Engaged the R&D teams to speed up drug development by:

  • defining core purpose and competencies of the CMC unit;
  • establishing a ‘project focused organization’ approach and skillset;
  • developing a ‘roadmap’ for an end-to-end view of CMC;
  • designing and resourcing the new organization;
  • strengthening collaboration with other R&D functions; and

allowing the company to gain marketing approval for its innovative formulation, the 1st of its kind (and doing so faster than competitors).

Get in touch

Has this case study inspired a similar demand in your company or would you like to learn more?

We will be glad to further help you.

Areas of Expertise

  • CMC
  • Organization & Process Design


  • Pharma


  • R & D
  • Development
Cookie Consent with Real Cookie Banner